Inactive Instrument

Health House International Stock

Equities

HHI

AU0000141368

Dynamic Chart
Health House International to be Removed from Australian Bourse's Official List MT
Creso Pharma Limited completed the acquisition of Health House International Limited. CI
Health House International Discloses Release of Shares from Escrow MT
Health House International Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Health House International Limited Auditor Raises 'Going Concern' Doubt CI
Health House International CEO to Step Down MT
Health House International Limited Announces Resignation of Paul Mavor as COO, Effective 2 December 2022 CI
Health House International Limited Announces Resignation of David Attwood, CEO, Effective 19 March 2023 CI
COVID-19 Resurgence in China Pushes Down Australian Shares MT
Creso Pharma Signs Deal to Acquire Health House; Creso Shares Fall 9% MT
Health House International Limited Announces Resignation of Henrik Sprengel as Executive Director CI
Sabine Jacker completed the acquisition of THCinol/CBDinol CanPharma GmbH from Health House International Limited. CI
Health House International Selling German Subsidiary for $0.99 MT
Sabine Jacker executed a binding terms sheet to accquire THCinol/CBDinol CanPharma GmbH from Health House International Limited for Ç1. CI
Health House International Limited announced that it has received AUD 0.4 million in funding from Celtic Capital Pty. Ltd. CI
More news
Managers TitleAgeSince
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 71 -
Director of Finance/CFO - -
More insiders
Health House International Limited is an international distributor specializing in the distribution of medicinal cannabis products across Australasia, United Kingdom and Europe. The Company is a fully licensed and regulated specialized importer, exporter, consolidator and distributor of medicinal cannabis products, distributing medicinal cannabis products to pharmacies, prescribers, specialist medicinal cannabis clinics and researchers across Australasia. It supplies pharmacies, hospital, government departments, veterinarians and other wholesalers with medicinal cannabis and general pharmaceutical products across the United Kingdom and Europe. The Company also integrates education of patients and healthcare professionals in the use of medicinal cannabis as a core part of its activities and is developing digital tools to enable a holistic understanding of usage.
Sector
-
More about the company